A Prospective, Randomized, Open-label, Comparative Study between Amlodipine and Diltiazem in Non-diabetic Patients of Mild to Moderate Hypertension

Abstract

Introduction: In developed countries hypertension is held responsible a fourth contributor to premature death, while it ranks seventh in developing countries. It is important to know this fact because even a 2 mmHg decrease can prevent 151,000 stroke and 153,000 coronary heart disease deaths in our country.Ca2+ channel blockers are effective and preferred drugs in lowering blood pressure and decreasing cardiovascular events in the elderly with isolated systolic hypertension. It is therefore imperative that we should have maximum data on their pattern of utilization and the adverse drug reactions.Aims and Objective: To observe and compare the anti-hypertensive efficacy as well as incidence of adverse drug reactions between amlodipine anddiltiazem.Materials and Methods: This prospective, comparative, open-label study included 80 patients suffering from stage I / II essential hypertension. These patients included males and females randomized in each study group. Observation and Result: In the present study, we observed that amlodipine anddiltiazem are effective agents in reducing both systolic and diastolic BP throughout the study period when measured at the 15thday, 30thday, 45thday and 90th day. A total of 39% of the patients reported some sort of adverse-effects like peripheral oedema (12.5%), nausea(5%), dizziness (5%), headache (7.5%) and , abdominal pain (2.5%) in the group1 and 24% in the diltiazem treated group 2, with noted adverse-effects like peripheral oedema (5%), nausea (5%), dizziness (5%), headache (5%) and abdominal pain (0%). Conclusion: The antihypertensive effect of these two drugs included in the study was statistically significant. These two drugs were equally effective in reducing the systolic and diastolic blood pressure. The incidence of peripheral oedema, abdominal pain and headache were more in amlodipine treated group than diltiazem treated group. However, this difference in the frequency of adverse-effects between the two groups was not statistically significant (P > 0.05). Adverse effects were tolerated by both the study groups and hence can be used as efficient antihypertensive drugs in management of essential hypertension.

Authors and Affiliations

Santosh C. Gursale , Sudheer Kumar , Narayan P. Burte , Mohankrishna Ghanta

Keywords

Related Articles

Lipoleiomyoma: Uncommon in Common

Inspite of common occurrence of leiomyomas in uterus, lipoleiomyomas are found to be as uncommon variants of uterine leiomyoma. The incidence is variously reported as 0.03-0.2%. Here we are discussing three such cases in...

Primary hyperparathyroidism parathyroid adenoma

Hyperparathyroidism is divided into primary, secondary, and tertiary hyperparathyroidism. Most parathyroid hyperplasia is the result of secondary hyperparathyroidism due to renal disease. Tertiary hyperparathyroidism is...

Placental thickness an estimator of fetal growth variables

Objectives: 1.To find out the relationships between fetus growth variables with placental thickness.2.To estimate the growth variables through the regression analysis models. Methodology: 240 III trimester ante-natal mot...

Vocal Cord Schwannoma - A Rare Case

[i][/i]Schwannoma of vocal cord are benign tumors. Most commonly involving aryepiglottic folds or false vocal cords, schwannoma involving true vocal cords is rare. We report a case of schwannoma presenting as vocal cord...

Study of correlation of serum protein levels with tuberculosis

Background: It is well established that changes in levels of serum proteins occur in response to both acute and chronic infections. This is especially true of immunoglobulins and acute phase proteins. Serum protein level...

Download PDF file
  • EP ID EP152331
  • DOI -
  • Views 84
  • Downloads 0

How To Cite

Santosh C. Gursale, Sudheer Kumar, Narayan P. Burte, Mohankrishna Ghanta (2014). A Prospective, Randomized, Open-label, Comparative Study between Amlodipine and Diltiazem in Non-diabetic Patients of Mild to Moderate Hypertension. INTERNATIONAL JOURNAL OF RECENT TRENDS IN SCIENCE AND TECHNOLOGY, 10(2), 196-201. https://europub.co.uk./articles/-A-152331